Y. Zang

Available identifiers

Publication	Date of Publication	Type
Two-stage marker-stratified clinical trial design in the presence of biomarker misclassification	2024-11-14	Paper
Optimal marker-adaptive designs for targeted therapy based on imperfectly measured biomarkers	2024-11-14	Paper
BIPSE: a biomarker-based phase I/II design for immunotherapy trials with progression-free survival endpoint	2024-10-29	Paper
A Bayesian adaptive marker-stratified design for molecularly targeted agents with customized hierarchical modeling	2024-10-29	Paper
A generalized phase 1-2-3 design integrating dose optimization with confirmatory treatment comparison	2024-10-28	Paper
BILITE: a Bayesian randomized phase II design for immunotherapy by jointly modeling the longitudinal immune response and time-to-event efficacy	2024-10-10	Paper
A Bayesian phase I/II clinical trial design in the presence of informative dropouts	2018-05-08	Paper
A boundary element method for time domain analysis of nonlinear fluid sloshing.	2001-12-18	Paper

This page was built for person: Y. Zang